Emma Wilkinson
Freelance Writer at Freelance
Award-winning freelance health journalist @pulsetoday, @bmj_latest, @PJOnline_News. Co-founder @freelancingfor. Vice-chair @mjauk. Runs up hills for fun.
Articles
-
2 weeks ago |
bmj.com | Emma Wilkinson
Making lives better when times are hard can seem an insurmountable challenge. But local initiatives with joined-up working can have an impact, reports Emma WilkinsonChildren born in 2008 in the UK have not yet hit their 18th birthday but have already lived through a global financial crisis, a period of austerity, a pandemic, and now a cost-of-living crisis. Inequality has widened in that time, and local authority budgets have been dramatically cut.
-
1 month ago |
bmj.com | Emma Wilkinson
A focus on stroke at the start of the century transformed treatments and improved outcomes, but pressure on the NHS has seen those advances stymied. Emma Wilkinson looks for a rebootA boost to stroke care investment and leadership in the early 2000s saw the number of people dying from the condition almost halved between 1990 and 2010. The effort was backed by the 2007 national stroke strategy, which redesigned services so as to get thrombolysis drugs into patients as quickly as possible.
-
2 months ago |
bmj.com | Emma Wilkinson
The government’s efforts to tackle antimicrobial resistance (AMR) have had limited impact, the National Audit Office (NAO) has warned. Despite taking the threat seriously, resistant infections have risen and the UK remains “a long way” from tackling the problem, the parliamentary watchdog found.1Only one of five targets set in 2019—cutting the use of antibiotics in food producing animals—has been met, the NAO investigation found.
-
2 months ago |
thelimbic.com | Emma Wilkinson
Clinicians need better guidance on identification and treatment of drug-induced erythrocytosis, say researchers who did a review of current evidence. The team found several classes of medications associated with erythrocytosis, including testosterone, SGLT-2 inhibitors, tyrosine kinase inhibitors, erythropoietin, and anti-TB medications. But they found limited evidence to guide clinical practice.
-
Jan 23, 2025 |
thepharmacist.co.uk | Emma Wilkinson |Megan Ford
Adults with ADHD ‘are living shorter lives than they should’, say researchers who analysed life expectancy in GP patient records. The UK study found a reduction in life expectancy for men with diagnosed ADHD of between 4.5 and 9 years, and between 6.5 and 11 years for women. It is likely to be a result of ‘modifiable risk factors’ as well as unmet support and treatment needs for both ADHD and co-occurring mental and physical health conditions, the team from University College London concluded.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 3K
- Tweets
- 9K
- DMs Open
- Yes
RT @joshi: 🚨 There are now 10,000 readers paying for @millmediauk journalism! Big milestone for our team, who are inspiring a renaissance i…
We've had a real flurry of sign ups in the past couple of days. Really looking forward to seeing our members there!
There are many reasons to register for our symposium with @HealthFdn on the 25th April, not least the number of exclusive news stories you'll miss out on if you're not there. Last chance to grab your place! https://t.co/3IeAElzpbw
RT @mjauk: There are many reasons to register for our symposium with @HealthFdn on the 25th April, not least the number of exclusive news s…
